3C-BZ
| 3C-BZ | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
3C-BZ is a chemical compound that belongs to the class of phenethylamines. It is structurally related to other compounds in the 3C family, which are known for their psychoactive properties. The compound is characterized by the presence of a benzyl group attached to the alpha carbon of the phenethylamine backbone.
Chemical Structure[edit]
The chemical structure of 3C-BZ includes a phenethylamine core with a benzyl group substitution. This structure is similar to other compounds in the 3C series, such as 3C-P and 3C-E, which also feature various substitutions on the phenethylamine backbone.
Pharmacology[edit]
The pharmacological effects of 3C-BZ are not well-documented. However, based on its structural similarity to other 3C compounds, it is likely to interact with the serotonin and dopamine receptors in the brain, potentially leading to psychoactive effects. Further research is needed to fully understand its pharmacodynamics and pharmacokinetics.
Legal Status[edit]
The legal status of 3C-BZ varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use. It is important to consult local regulations to determine its legal status in a specific area.
Related Compounds[edit]
See Also[edit]
References[edit]
